Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.03
+0.02000.40%
Post-market: 5.00-0.0300-0.60%19:34 EDT
Volume:1.21M
Turnover:6.12M
Market Cap:286.96M
PE:-4.49
High:5.11
Open:5.09
Low:4.99
Close:5.01
52wk High:7.65
52wk Low:4.00
Shares:57.05M
Float Shares:36.92M
Volume Ratio:1.11
T/O Rate:3.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1200
EPS(LYR):1.01
ROE:-43.13%
ROA:-24.55%
PB:2.24
PE(LYR):4.98

Loading ...

Abeona Therapeutics Grants Inducement Awards for up to 7,200 Restricted Shares to New Hires

Reuters
·
Yesterday

Abeona Therapeutics® Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Yesterday

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 22

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Abeona Therapeutics® Congratulates Ultragenyx on U.S. FDA Approval of Fayuvi™ Gene Therapy for Sanfilippo Syndrome Type a (Mps Iiia)

THOMSON REUTERS
·
Sep 18

Abeona Therapeutics price target raised to $30 from $28 at Cantor Fitzgerald

TIPRANKS
·
Sep 18

Abeona Therapeutics initiated with a Buy at Roth Capital

TIPRANKS
·
Sep 17

Abeona Therapeutics Activates 8th ZEVASKYN Treatment Center in Florida

MT Newswires Live
·
Sep 16

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for Zevaskyn®

THOMSON REUTERS
·
Sep 16

Abeona Therapeutics Updates Investor Presentation at Conference

TIPRANKS
·
Sep 16

Abeona Therapeutics Management to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 02

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
Sep 02

Abeona Therapeutics Sees Major Insider Move From Company Director

TIPRANKS
·
Sep 02

Abeona Therapeutics Director Mark Alvino Disposes of 15,000 Common Shares Worth $87,966

Reuters
·
Sep 02

Abeona Therapeutics Grants 13,300 Restricted Shares to Five New Hires Under NASDAQ Inducement Plan

Reuters
·
Sep 01

Abeona Therapeutics® Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 01

High Insider Ownership Growth Stocks To Watch In August 2026

Simply Wall St.
·
Aug 22

Abeona Therapeutics reports Q2 EPS (35c), consensus (25c)

TIPRANKS
·
Aug 17

Abeona Therapeutics is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 15

Oppenheimer Adjusts PT on Abeona Therapeutics to $21 From $22, Maintains Outperform Rating

MT Newswires Live
·
Aug 14